Our stem cell expansion and screening technologies have enabled us to generate quality-assured stem cell lines in quantities sufficient to treat many hundreds of thousands of potential patients. Read More ....

We have developed stem cell therapies for serious conditions such as stroke disability where the patient populations are significant and where few if any alternative treatments exist. Read More ....

To view detailed share price information
for ReNeuron Group plc. Click Here

ReNeuron is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need. Read more ....